Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

Holiday weight gain hits home for many come January. These days, folks making resolutions to slim down and get fit have an ...

Maridebart cafraglutide, a novel injectable GIP receptor antagonist/GLP-1 receptor agonist, reduced body weight by ...

Everything you need to know about using Ozempic, Wegovy, and Mounjaro to shed those extra pounds. We dive into their perks, ...

The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but potentially serious sleep-related breathing disorder, marking it the ...

The study stated that weight loss drugs can affect bone and muscle mass, leading to chronic illnesses and risk of fractures. For the longest time, people resorted to diet and exercise for losing ...

But for other people who are using these medications specifically for weight loss, the risks would be different."We would expect that a person would have less appetite suppression and more quick ...

Officials say the state’s Medicaid program hasn’t been covering certain weight loss drugs, despite a state law passed last year that requires it to do so. In 2023, the legislature expanded ...

Drugs like Ozempic and Wegovy have skyrocketed in popularity over the past few years. To capitalize on that demand, telehealth companies started offering compounded versions of those drugs.

Compounded by the equally sudden banning of the weight loss drug, phen-fen (phentermine-fenfluramine ... It wasn't until 2021 when the FDA approved wegovy for the treatment of adults with ...

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss drug Zepbound. The medicine, part of the class known as GLP-1 ...